ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • Abstract Number: PB1514

    Targeted High-throughput Sequencing for Genetic Classification of Patients with Inherited Platelet Disorders

    H. Schulze1, G. Manukjan1, E. Klopocki2, O. Andres1, GPOH/GTH Study Group 'ThromKid-Plus' on Inherited Platelet Disorders

  • Abstract Number: PB0755

    Targeted Measurement of Plasmin Kinetics on the Activated Platelet Membrane

    M. Simpson, B. Veuskens, C.S. Whyte, N.J. Mutch

  • Abstract Number: PB1733

    Targeting of a Conserved Epitope in Mouse and Human GPVI Differently Affects Receptor Function and in vivo Depletion

    S. Navarro1,2, H. Brown1,2, M. Kuijpers3, J. Heemskerk3, D. Stegner1, B. Nieswandt1,2

  • Abstract Number: PB1661

    Targeting the Chemokine Receptor CXCR7 Favours an Anti-thrombotic Platelet Lipidome and Regulates Thromboinflammatory Functions

    L. Pezl1, M. Cebo2, K. Althaus1, D. Rath3, M. Lämmerhofer2, M. Gawaz3, T. Bakchoul1, M. Chatterjee3

  • Abstract Number: PB0098

    Temporary Hypofibrinogenemia in Reversible Cerebral Vasoconstriction Syndrome (SRVC) Associated a Cannabis Overdose

    S. Herrero1, G. Carvalho2, J. Hernández2, B. Merchán1

  • Abstract Number: PB2263

    Ten Years of Venous Thromboembolism Events in a Large Teaching Hospital: Changing Patterns of Disease

    H. Rowswell, T. Nokes

  • Abstract Number: PB0827

    Testing the Impact of Recombinant von Willebrand Factor and Recombinant Factor VIII on Osteoclastogenesis

    H. Haidl, S. Pohl, T. Strini, M. Tischitz, S. Gallistl, A. Schlagenhauf

  • Abstract Number: PB1896

    Tetra Positive Thrombotic Antiphospholipid Syndrome: Major Contribution of Anti Phosphatidyl-Serine/Prothrombin Antibodies to Lupus Anticoagulant Activity

    M. Cattini, E. Bison, E. Pontara, C.-Y. Cheng, G. Denas, V. Pengo

  • Abstract Number: PB1734

    Tetraspanin CD9 Regulates GPIIb-IIIa-Mediated Platelet Function: Identification of Unique Protein Interactomes

    J. Kotha1, X. Zhai1, M. Herr1,2, S. Hill3, L. Jennings1

  • Abstract Number: OC 10.2

    The ALK Rearrangement is a Major Risk Factor for Venous and Arterial Thrombosis in Non-Small Cell Lung Cancer

    H. Al-Samkari1,2, O. Leiva2,3, I. Dagogo-Jack2,4, A. Shaw2,4, P. Bendapudi1,2, J. Connors2,5

  • Abstract Number: PB1594

    The VWF Variant D1472H Affects VWF Binding to Ristocetin in vitro in the Platelet Agglutination Assay but Not with Latex Particles (HemosIL® Acustar VWF:GpIbR): The Usefulness to Change Practices to Avoid VWD Genotyping

    F. Lassalle1, E. Jeanpierre1, C. Zawadzki1, P. Boisseau2, A. Veyradier3, A. Rauch1, J. Goudemand1, S. Susen1

  • Abstract Number: PB0985

    The 2-Years Successful Experience of Immune Tolerance Induction (ITI) with High-Purity Human FVIII/ von Willebrand Factor (vWF) in Hemophilia A Patients

    M. Savitri, A. Ashariati

  • Abstract Number: PB1140

    The 2020 World Federation of Hemophilia Guidelines for the Management of Hemophilia

    A. Srivastava1, G. Pierce2, S. Zelman Lewis3, D. Coffin2, D. Hum4

  • Abstract Number: PB1607

    The Ablation of Collagen VI Leads to the Release of Platelets with Altered Functions

    V. Abbonante1,2, C.A. Di Buduo1,2, M. Battiston3, M. Chrisam4, L. Sereni5, C. Semplicini6, A. Villa5,7, E. Pegoraro6, P. Braghetta4, L. De Marco3, P. Bonaldo4, A. Balduini1,2

  • Abstract Number: PB/CO14

    The Acquired Coagulopathy of COVID-19

    F. Peyvandi1,2, A. Artoni2, C. Novembrino2, S. Aliberti1,3, M. Panigada4, M. Boscarino2, R. Gualtierotti1,2, R. Palla1, F. Rossi2, I. Martinelli2, G. Grasselli1,4, F. Blasi1,3, A. Tripodi2

  • Abstract Number: PB2160

    The Activated Coagulation Factor X (FXa) Directly Stimulates Colorectal Cancer Cell Migration and Proliferation – Characterizing the Underlying Molecular Mechanisms

    U. Meyer, S. Polster, E. Moritz, B.H. Rauch

  • Abstract Number: PB1645

    The Active Recruitment of Red Blood Cells to Activated Platelets via CD36 and FasR Is Crucial for Arterial Thrombus Formation

    K. Krott, M. Elvers

  • Abstract Number: PB2363

    The Added Benefit of Mechanical Compression to Prevent VTE after Hip or Knee Arthroplasty: Post-Hoc Analysis of the EPCATII Study

    C.J.M. Green, S. Shivakumar, C. Theriault, S. Doucette, S. Pleasance, D. Anderson

  • Abstract Number: PB1129

    The Age Dependent Effects of Female Sex on Platelet Behavior after Injury

    Z. Matthay, M. Patel, A. Fields, B. Nunez-Garcia, E. Ross, J. Park, R. Callcut, L. Kornblith

  • Abstract Number: PB0854

    The Annual Global Survey Continues to Close the Gap in Data Collection of Bleeding Disorders

    E. Tootoonchian1, J. Stonebraker2, A. Iorio3, V. Byams4, M. El Ekiaby5, M. Makris6, J. O'Hara7, H. Chambost8, A. Weill1, G. Pierce1, A. Baumann1, D. Coffin1

  • Abstract Number: PB1985

    The Anti-Inflammatory Effects Of 3´-Hydroxygenkwanin from Aquilaria sinensis in Human Neutrophils

    H.R. Liao1,2, J.-J. Chen3, S.-Y. Wang4

  • Abstract Number: PB0229

    The Anticoagulant Effect of Protamine – A Stabilizer of the Factor V Procofactor State

    T. Petrillo1, B.C. Remick1, R.M. Camire1,2

  • Abstract Number: PB0064

    The Antidepressant Drug Desipramine Prevents Arterial Thrombosis in a Mouse Model Carrying the Human BDNFVal66Met Polymorphism

    L. Sandrini1, P. Amadio1, A. Ieraci2, A. Malara3,4, J.P. Werba1, P.M. Soprano3,4, A. Balduini3,4, M. Zarà1, A. Bonomi1, F. Veglia1, G. Colombo1, F.S. Lee5, E. Tremoli1, S.S. Barbieri1

  • Abstract Number: PB1961

    The Antioxidant and Antiinflammatory Effect of Synbiotic Beverage from Soybean Water Kerfir on Aortic Tissue of Hyperlipidemic Rats Model

    M. Afifudin1, E. Marfianti2

  • Abstract Number: PB0199

    The Antiplasmin Activity of the Kunitz Protease Inhibitor Domain of Protease Nexin 2 Affects Thrombolysis and Thrombosis in Mouse Models

    L. Eltringham-Smith1, V. Bhakta1, W. Sheffield1,2

  • Abstract Number: PB2358

    The Application of the Lymphoma International Prognostic Index (IPI) to Predict Venous Thromboembolic Events (VTE) in Patients with Diffuse Large B-Cell Lymphoma (DLBL)

    H. Abdel-Razeq, M. Ma'koseh, R. Mansour, R. Amarin, A. Abu Fara, M. Manassra, M. Alrwashdeh, R. Bater

  • Abstract Number: PB2366

    The Application of the Original and a Modified Version of the ThroLy Risk Assessment Model (RAM) to Predict Venous Thromboembolic Events (VTE) in Patients with Diffuse Large B-Cell Lymphoma (DLBL)

    H. Abdel-Razeq, M. Ma'koseh, A. Mansour, R. Amarin, A. Abu Fara, R. Bater, M. Manassra, M. Alrwashdeh, M. Zmaily, M. Almomani

  • Abstract Number: PB1808

    The Assessment of Platelet Membrane Alteration in Patients with Chronic Myeloproliferative Neoplasms

    V. Popov1, C.O. Matei2, M. Andreescu3, M.G. Moisescu2, T. Savopol2

  • Abstract Number: PB2081

    The Association between Neighborhood Socioeconomic Status, Geographical Area and Non-persistence to Using DOACs

    N. van Rein1,2, G.D. Zielinkski1, E.M. Ras1, M. Teichert3, F.A. Klok4, F.R. Rosendaal1, F.J.M. van der Meer4, M.V. Huisman4, S.C. Cannegieter1,4, W.M. Lijfering1

  • Abstract Number: OC 13.4

    The Association between Platelet Count and Perioperative Bleeding Complication in a Cohort of Cirrhotic Patients Undergoing Surgical Excision of Hepatocellular Carcinoma

    V. Ronca1, G. Podda1, R. Santambrogio2, M. Barabino2, E. Opocher2, P.M. Battezzati3, M. Zuin3, M. Cattaneo1

  • Abstract Number: PB2313

    The Association of BMI and Waist Circumference Improves the Prediction of VTE Risk as Compared to BMI Alone

    L.M. Caiano1, W. Ageno1, S. Costanzo2, T. Panzera2, M.P. Donadini1, M.B. Donati2, L. Iacoviello2

  • Abstract Number: PB0277

    The Association of Prothrombin Complex Concentrates with Transfusion Requirement and Postoperative Outcomes in Cardiac Surgery: A Post-Hoc Analysis of the FIBRES Randomized Controlled Trial

    J. Bartoszko1, K. Karkouti2, J. Callum3,4, on Behalf of the FIBRES Study Investigators

  • Abstract Number: PB2557

    The Attitudes of Haemophilia Carriers towards Prenatal Diagnosis and Mode of Delivery

    O. Turan, J. Davies, D. Pollard, M. Musarara, R. Abdul-Kadir

  • Abstract Number: PB0593

    The Basic Evaluation of Light Transmission Platelet Aggregation Method on an Automated Coagulation Analyzer CN-6000

    M. Egashira1, M. Kono2, K. Nakajima2, T. Sakayori1

  • Abstract Number: PB0531

    The Basic Evaluation of the Newly Developing Modified Diluted Prothrombin Time Reagent for Direct Oral Anticoagulants Measurements

    O. Kumano1, S. Suzuki2, M. Yamazaki3, Y. An4, M. Yasaka5, M. Ieko6, the Japanese Study Group for the Effect Confirmation of Direct Oral Anticoagulants

  • Abstract Number: PB0501

    The CDC Hemophilia A Mutation Project (CHAMP) F8 Mutation List: 2020 Update

    A.B. Payne, C.H. Miller, C.J. Bean

  • Abstract Number: PB1886

    The Changing Face of Thrombotic Thrombocytopenic Purpura (TTP) in South Africa in the Human Immunodeficiency Virus (HIV) Era

    S. Louw1,2, E.S. Mayne2,3, M. Meiring4,5, A. Mmakgabu4, R. Gounden1,2

  • Abstract Number: PB2331

    The Characteristics of Patients with Isolated Superficial Vein Thrombosis of the Legs, their Follow-up and Outcomes

    J. Hirmerová1, J. Seidlerova1, I. Subrt2, Z. Hajsmanova3

  • Abstract Number: PB0982

    The CHiC Study: The Canadian Hemophilia Carriers Study – Preliminary Results

    K. de Repentigny1, M. Hinds1, J. Grabell1, A. Keepanasseril2, A. Iorio3, N. Rydz4, S. Jackson5, S. Robinson6, L. Sun7, M. Belletrutti7, P. James1

  • Abstract Number: PB1022

    The Clinical Phenotype of Patients with Non-severe Hemophilia A and B

    A.-F. Zwagemaker1, F.R. Kloosterman1, E.A.M. Beckers2, J.G. van der Bom3,4, S. Boyce5, P.P. Brons6, P.W. Collins7, M. Coppens8, S.C. Gouw1, C. Harrison9, F.W.G. Leebeek10, F.J.M. van der Meer11, K. Meijer12, L. Nieuwenhuizen13, K. Fijnvandraat1,14, DYNAMO Study Group

  • Abstract Number: PB0974

    The Clinical Picture in Romanian Patients with Severe Forms of Hemophilia A: What Role did the Intron 22 Inversion and Age Play?

    M.-A. Gaman1,2, M. Brinza3, V. Uscatescu3, A. Diaconu3, A. Grigore4, M. Dragomir3, D. Coriu1

  • Abstract Number: PB0082

    The Clinical Predictors of Coronary Artery Disease: A Population-based Study from Developing Country

    M.F. Addai1, A.B. Setyani2, F. Ramdhitabudi3, J.H. Haposan4, A.K.T. Haruni5, A.M. Soesanto6

  • Abstract Number: PB0284

    The Comparison of Critical Care Instrument CoaguChek® Pro II with Coagulation Analyzers Sysmex CS-5100 and Cobas t 511

    M. Pulcer1,2, J. Gumulec2, L. Recova2, S. Kolarova2, Z. Svagera1, D. Stejskal1,2

  • Abstract Number: PB1562

    The Compound Heterozygosity with Two in Cis Mutations p.R924Q and p.A2178S in the D’D3 and D4 Domain Causes a Type 2B-Like von Willebrand Disease

    S. Lancellotti1, M. Sacco2, M. Tardugno2, E. De Candia2, L. Di Gennaro3, M. Basso1, B. Giusti4, G. Castaman5, R. De Cristofaro2,3

  • Abstract Number: PB1491

    The contribution of flow cytometry in the diagnosis of inherited thrombocytopathies

    H. Brouk, M. Rachi, A. Amireche, H. Ouelaa

  • Abstract Number: PB0891

    The Current State of Biochemical Marker Research in Hemophilic Arthropathy: A Review

    E.D.P. van Bergen1, L.F.D. van Vulpen1, R.E.G. Schutgens1, S.C. Mastbergen2, F.P.J.G. Lafeber2

  • Abstract Number: PB0379

    The Diagnostic and Prognostic Role of Protein C and Padui Scale for Prediction of Lung Vessel Thrombosis in Patients with Community-Acquired Pneumonia

    M. Krykhtina, K. Bielosludtseva, T. Pertseva

  • Abstract Number: PB0427

    The Diagnostic Significance of Platelet-Derived Microparticles Quantification by Flow Cytometry in Egyptian Patients with Ischemic Heart Disease

    N. Farouqe1, M. Wahba1, A. Saad1, R. El-Gamal1, Y. Elsakhawy1, M. Farouk2

  • Abstract Number: PB0228

    The Distribution of Hemophilia A-causing Genetic Variants by Race/Ethnicity and Association with Inhibitors among Enrollees in the Hemophilia Inhibitor Research Study (HIRS)

    A.B. Payne1, J. Driggers1, D. Ellingsen1, C. De Staercke1, C.H. Miller1, B. Boylan1, F.M. Bethea1, J.M. Soucie1, U.M. Reiss2, G. Young3, C.J. Bean1, Hemophilia Inhibitor Research Study Investigators

  • Abstract Number: PB2133

    The Downregulation of Mucin1 Initiates Aberrant Calcium Signalling Pathways of Cancer Cells which Are Partly Responsible for the Procoagulant Phenotype

    Y. Chen, M. Scully

  • Abstract Number: PB/CO16

    The Effect of Anticoagulation on Mortality in COVID-19 Patients: The Drug, the Dose, and the D-Dimer

    H. Billett1, M. Reyes Gil2, J. Szymanski2, K. Ikemura2, L. Stahl3, Y. Lo4, S. Rahman1, J. Gonzalez Lugo1, M. Kushnir1, M. Barouqa2, L. Golestaneh5, E. Bellin4

  • Abstract Number: PB1389

    The Effect of Aspirin in Tumor Growth of Obese Mice Involving Inhibition of Metabolism

    J.-D. Wang1, C.-J. Chen2, W.-Y. Chen3, J.-R. Li4, S.-Y. Lin4, Y.-Y. Wang5

  • Abstract Number: PB1138

    The Effect of Bypassing Agents in Combination with Emicizumab-treatment

    N.H. Schultz1,2,3, H. Glosli4,5, S. Bjørnsen6, P.A. Holme1,2,7

  • Abstract Number: PB1709

    The Effect of Ceramic Materials on Platelet Aggregation

    A.D. Nikanorova1, I.P. Antropova2,3, M.V. Gilev2,3, M.U. Izmodenova2,3, S.L. Khatsko1, I.M. Petrova1

  • Abstract Number: PB0652

    The Effect of DOAC-Stop® on Several Oral and Parenteral Anticoagulants

    N. Riva1, K. Vella2, K. Hickey3, P. Gatt4, C. Grima4, D. Zammit2, S. Kitchen3, M. Makris3, W. Ageno5, A. Gatt1,2

  • Abstract Number: PB0629

    The Effect of Haemolysis in Patient Samples on Coagulation Tests Performed on ACL TOP 550

    K. Hickey, A. Woolley, S. Kitchen

  • Abstract Number: PB1641

    The Effect of IL-6-Primed Platelets on ADAMTS13-Mediated Clearance of Platelet-Bearing ULVWF and its Mechanism

    H.-J. Kim1, Y. Song1, J.-F. Dong2, H.-I. Jung3, J. Song1

  • Abstract Number: PB1880

    The Effect of Liver Transplantation on ADAMTS13 Activity and Antigen Levels

    T. Falter1, F. Häuser1, F. Hofsaess1, L. Greulich2, M. Sprinzl3, K. Lackner1, I. Scharrer4, B. Lämmle4,5,6, J. Mittler7

  • Abstract Number: PB1401

    The Effect of Plasma Fibrinogen Level on Predictive Value of VerifyNow P2Y12 Assay Results in Patients Undergoing Percutaneous Coronary Interventions

    A. Dobrovolsky1, P. Laguta1, E. Titaeva1, A. Komarov1, E. Novikova1, E. Guskova1, E. Yarovaya2, E. Panchenko1

  • Abstract Number: PB2476

    The Effect of Postoperative Analgesia on the Hemostatic System in Gerontological Patients with Multiple Trauma

    Y. Volkova, K. Mikhnevich, M. Dolzhenko

  • Abstract Number: PB0380

    The Effect of Protein C on Various Links of Hemostasis

    A. Makhmudova, I. Berger, L. Ashurova, N. Juraeva

  • Abstract Number: PB0524

    The Effect of RBCs on Different Platelet Count Enumeration Methods in Patients with Hemoglobinopathies

    R. Shekhar1, S. Pai2, S. V1, V. Bhat2

  • Abstract Number: PB2466

    The Effect of rs4148738 Polymorphism of ABCB1 on the Plasma Concentrations of Direct Oral Anticoagulants and Bleeding an Thromboembolic Complications

    B. Cosmi1, L. Salomone1, M. Cini2, G. Guazzaloca1, C. Legnani2

  • Abstract Number: PB0765

    The Effect of the Fibrino(geno)lytic Enzymes from Tissues of Antarctic Hydrobionts on Hemostasis

    N. Raksha, O. Savchuk, L. Ostapchenko

  • Abstract Number: PB0587

    The Effect of trough Dabigatran Plasma Concentration on Thrombin Generation

    M. Milic1,2, J. Stanfel1, K. Paradinovic1, V. Seric1

  • Abstract Number: PB1710

    The Effect of γ-Irradiation at a Dose of 1 Gy on Calcium Metabolism in Rat Platelets

    V. Bichan1, V. Parkhimovich2, K. Bulanova2

  • Abstract Number: PB0727

    The Effects of (Patho)Physiological Fibrinogen γ’ Levels on Static and Dynamic Clot Formation

    F. Macrae1, F. Swieringa2, M. Pieters3, J. Heemskerk2, R. Ariëns1

  • Abstract Number: PB0391

    The Effects of Acids on Whole Blood Coagulation is Depended on the Type of Acid and Concentration as Assessed by Thromboelastography (TEG)

    G. Ogweno1, B. Chege2, P. Waweru3

  • Abstract Number: PB1651

    The Effects of E.coli Lipopolysaccharides on Platelet Function Are Limited to Re-Sensitization

    A. Martyanov1,2,3, A. Maiorov1, A. Filkova1,2, A. Ryabukh2, M. Panteleev1,2, A. Sveshnikova1,4

  • Abstract Number: PB0596

    The Effects of EDTA as an Anticoagulant and Delayed Processing on the Measurement of Plasma VWF Antigen

    M.C. Sims1,2,3, F. Moenen4, R. Wetzels5, R. van Oerle5, M. Laffan2,6, S. Shapiro2, W.H. Ouwehand1,3,7, M. Frontini1,3,7, Y. Henskens5, NIHR BioResource

  • Abstract Number: PB1969

    The Effects of Hypoxia on Activation of Endothelial Cells

    C. Ullsten-Wahlund, J.-B. Hansen, O. Snir

  • Abstract Number: PB1691

    The Effects of Platelet Agonists and Priming on Platelet Populations

    A. Veninga1, C.C.F.M.J. Baaten2, B.M.E. Tullemans1, M.J.E. Kuijpers1, J.W.M. Heemskerk1, P.E.J. van der Meijden1

  • Abstract Number: PB0109

    The Epinephrine-induced Platelet Aggregation Changes in Arterial Hypertension of Very High Risk

    E. Shorikov1, D. Shorikova1, P. Shorikov2, O. Khukhlina1

  • Abstract Number: PB/LB04

    The eTHINK Study: Cognitive and Behavioral Outcomes in Children with Hemophilia

    C. Mrakotsky1, C. Buranahirun2, D.L. Cooper3, S.E. Croteau1, M. Greybels4, C. Hannemann5, M. Rajpurkar6, K.A. Shapiro7, G.N. Wilkening8, P. Ventola9, K.S. Walsh10, on behalf of the eTHINK Study Group

  • Abstract Number: PB0926

    The Experience of Orthopedic Surgeries in Ukrainian Hemophilia Patients with Inhibitor

    Y. Kashpurenko1, K. Vilchevska1, I. Bakhchyvandzhy1, V. Vitiaz2

  • Abstract Number: PB1188

    The F7 p.Val22Ile Missense Mutation Affects Splicing and Can Be Counteracted by a Compensatory U1snRNA

    P. Ferraresi1, L. Rizzotto1,2, A. Branchini1, M. Baroni1, D. Balestra1, F. Bernardi1, F. Pagani3, M. Pinotti1

  • Abstract Number: PB0776

    The FARES Study: A Multicenter, Randomized, Active-Control, Pragmatic, Phase 2 Pilot Study Comparing Prothrombin Complex Concentrate versus Frozen Plasma in Bleeding Adult Cardiac Surgical Patients

    K. Karkouti1, J. Callum2

  • Abstract Number: PB1774

    The Fc and C1/C2 Domains of Recombinant Factor VIII Fc Fusion Protein Engage Monocytes in an FcgammaRII-Dependent Manner to Reduce Their Differentiation Potential into Osteoclasts

    S. Duan, K. Kis-Toth, G. Rajani, R. Peters, J. Salas

  • Abstract Number: PB0969

    The Feasibility of Teaching Handheld Ultrasound (HHUS) for Home Use to Identify Bleeding in Hemophilia

    B. Steiner, M. Krimmel, M. Ewert, S. Lynch, R. Kruse-Jarres

  • Abstract Number: PB0734

    The Fibrinogen αC Region Is a Major Contributor to the Mechanical Strength of Fibrin Fibers

    A. Daraei1, N. Hudson2, T. Dement2, M. Guthold1

  • Abstract Number: OC 05.1

    The Fibronectin Type II Domain of Factor XII Prevents Inappropriate Zymogen Activation

    C.C. Clark1, Z.L.M. Hofman1,2, W. Sanrattana1, L. den Braven1, S. de Maat1, C. Maas1

  • Abstract Number: PB0204

    The FibWave, a New Sensitive and Relevant Tool for Analysing the fibrin Clot Formation: Comparison with the Calibrated Automated Thrombogram to Assess Direct Oral Anticoagulants

    J. Evrard1, L. Morimont1,2, R. Siriez1, J.-M. Dogné1, J. Douxfils1,2

  • Abstract Number: PB1288

    The Frequencies of Thrombophilic DNA Polymorphisms in Children with Hemolytic Uremic Syndrome from the North-Western Region of Russia

    E. Pankov1, K. Papayan1, N. Savenkova1, S. Kapustin2, L. Papayan2

  • Abstract Number: PB0486

    The Functional Profiles of Platelets Collected from Blood Diversion Pouches and Apheresis Concentrates Are Comparable to the Ones from Platelets Isolated through Standard Methods

    P. Davizon-Castillo1, K. Kelly2, M. Kelher3, M. Manco-Johnson4, C. Silliman5, L. Dumont2

  • Abstract Number: PB0718

    The Glycan Structure Associated to Factor XIII Subunit B and its Functional Importance

    B. Hurják1, Z. Kovács2, É. Katona1, K. Pénzes1, G. Haramura1, F. Sadeghi1, A. Shemirani1, A. Guttman2, L. Muszbek1

  • Abstract Number: PB2016

    The Gut Microbiota Restricts NETosis in Acute Mesenteric Ischemia-Reperfusion Injury

    S. Ascher1, E. Wilms1, H. Formes1, M. Müller1, G. Pontarollo1, F. Malinarich1, K. Jurk1, C. Reinhardt1,2

  • Abstract Number: PB1000

    The Haemophilia A Patients whose FVIII: C by Chromogenic Substrate Assay were Higher than by One-Stage Substrate Assay Showed Risk of Development of Haemophiliac Arthropathy Silently

    N. Suzuki1, N. Takahashi1, A. Suzuki2, S. Tamura3, S. Suzuki3, Y. Hattori3, M. Kakihara3, M. Ogawa4, T. Kanematsu2, T. Kojima4, T. Kojima3, H. Kiyoi4, N. Ishiguro4, T. Matsushita2

  • Abstract Number: PB1046

    The Health Status of Older Patients with Hemophilia in the Netherlands

    S. Hassan1, E.C. van Balen1, C. Smit1, E.P. Mauser-Bunschoten2, L.F.D. van Vulpen2, J. Eikenboom3, E.A.M. Beckers4, L. Hooimeijer5, P.F. Ypma6, L. Nieuwenhuizen7, M. Coppens8, S.E.M. Schols9,10, F.W.G. Leebeek11, M.H.E. Driessens12, F.R. Rosendaal1, J.G. van der Bom1,13, S.C. Gouw1,14

  • Abstract Number: PB1576

    The Homozygous Variant p.Gln1311* in Exon 28 of VWF Is Causing Type 3 von Willebrand Disease and Is at High Risk of Allo-Immunisation

    F. Lassalle1, C. Zawadzki1, P. Boisseau2, E. Jeanpierre1, A. Rauch1, C. Paris1, A. Hochart1, Y. Repesse3, A. Veyradier4, A. Harroche5, C. Biron-Andréani6, C. Falaise7, J. Goudemand1, S. Susen1

  • Abstract Number: PB2422

    The Impact of an Educational Intervention in Patients with Atrial Fibrillation Treated with Warfarin

    J.M. Costa1, M.S. Marcolino2, H.C. Torres3, R.P. Souza4, M.F.S. Praxedes5, H.C. Barbosa6, S.D.S. Barros1, A.C. Viegas1, D.V. Nascimento1, C.B. Ferreira1, N.S. Antunes7, A.C.R. Silva1, D.D. Ribeiro7, M.A.P. Martins1

  • Abstract Number: PB2344

    The Impact of Body Mass Index (BMI) Dynamics on the Risk of Venous Thromboembolism Recurrence (VTE)

    L. Padrnos1, T. Petterson2, K. Bailey2, K. Lackore2, A. Ashrani3

  • Abstract Number: PB2542

    The Impact of Hydroxychloroquine on the Prevention of Severe Preeclampsia in Patients with Obstetric Anti-Phospholipid Syndrome

    F. Aranda1, J.O. Latino2, S. Udry1, S. Perés1, D.S. Fernández Romero2, G. de Larrañaga1

  • Abstract Number: PB1010

    The Impact of Physical Activity on the Pharmacokinetics of Factor VIII / IX in a Cohort of Pediatric Patients with Hemophilia A / B in Pharmacological Prophylaxis

    C. Pastore, G. Lassandro, A. Amoruso, V.V. Palmieri, V. Palladino, P. Giordano

  • Abstract Number: PB2084

    The Impact of Soluble Thrombomodulin and Circulating miRNAs on Catheter Ablation in Patients with Atrial Fibrillation

    F. Namino1, M. Yamakuchi1, Y. Iriki2, Y. Ninomiya2, H. Ichiki2, R. Maenosono1, I. Masamoto1, M. Ohishi2, T. Hashiguchi1, I. Maruyama3

  • Abstract Number: PB2206

    The Impact of Successful Ultrasound-Accelerated Catheter-Directed Thrombolysis on the Prevention of Post-Thrombotic Syndrome: A Post-Hoc Analysis of the CAVA-Trial

    P. Notten1,2, C. Arnoldussen3,4, R. Brans3, A. de Smet5, L. Tick6, M. van de Poel7, O. Wikkeling8, L.-J. Vleming9, A. Koster10, K.-S. Jie11, E. Jacobs12, H. Ebben13, N. Planken14, C. Wittens15, H. ten Cate2,16,17, A.J. ten Cate-Hoek2,16,17

  • Abstract Number: PB0971

    The Impact of Switching Previously Treated Patients (PTPs) to Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Reducing the Annualized Bleeding Rate (ABR): A Single Center Experience

    O. Benítez, M. Suito, A. Cabirta, J.C. Juarez, M.F. Martinez, G. Robayo, E. Alvarez, C. Fernandez, N. Soto, R. Cardona, M. Gironella

  • Abstract Number: PB1569

    The Impacts of Genetic Polymorphisms on the Von Willebrand Factor Level in Type 1 Von Willebrand Disease

    Y.-C. Chen1, C.-Y. Chang2, S.-N. Cheng3, S.-H. Hu2

  • Abstract Number: PB0440

    The Importance of Altered Symmetric Dimethylarginine Levels with Platelet Hyperreactivity in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

    C. Eyileten1, J. Jarosz-Popek1, A. Soplinska1, Z. Fitas1, A. Nowak1, L. Zareba1, G. von Baumgarten1, P. Czajka1, D. Jakubik1, J. Siller-Matula1,2, M. Ufnal3, M. Postula1

  • Abstract Number: PB2381

    The Incidence of Venous Thromboembolism along with Adherence to Guideline in Major Orthopedic Surgery

    H.G. Hwang1, S.-M. Koo2, Y.-K. Kim2

  • Abstract Number: PB2456

    The Increasing Bleeding Risk from Drug-drug Interactions in Patients with Direct Oral Anticoagulants

    S.-M. Bang1, J.Y. Lee1, I.-Y. Oh1, J.-H. Lee1, S.-Y. Kim2, S.-S. Kwon2, H.-J. Yang2, Y.-K. Kim2

  • Abstract Number: PB1957

    The Induction Strategies Administered in the Treatment of Multiple Myeloma Exhibit a Deleterious Effect on the Endothelium

    J. Martinez-Sanchez1,2,3, M. Palomo1,2,3, S. Torramade-Moix2, A.B. Moreno-Castaño2, M. Rovira4, G. Gutiérrez-García4, F. Fernandez-Aviles4, G. Escolar2, O. Penack5,6,7, L. Rosiñol4,8, E. Carreras1,3, M. Diaz-Ricart2,3

  • Abstract Number: PB2309

    The Influence of Anemia on Clinical Outcomes in Venous Thromboembolism: Results from GARFIELD-VTE

    S. Goto1, A.G.G. Turpie2, A.E. Farjat3, J.I. Weitz2,4, S. Haas5, W. Ageno6, S.Z. Goldhaber7, P. Angchaisuksiri8, J. Dalsgaard Nielsen9, G. Kayani3, P. MacCallum3,10, S. Schellong11, H. Bounameaux12, L.G. Mantovani13,14, P. Prandoni15, A.K. Kakkar3,16

  • Abstract Number: PB0756

    The Influence of Prothrombin Complex Concentrates on Clot Stability

    C.D. Garcia, P. Chowdary, M.R. Peralta, Z. Hanif, A. Riddell, P. Lawler, L. Dailani, C. Hamid

  • Abstract Number: PB1746

    The Inhibitory Mechanism of Adiporon during Platelet Activation

    X. Zhou, Z. Cheng, Y. Hu

  • Abstract Number: PB0132

    The Initial Formation of a Transient Sub-Occlusive Mural Thrombus Appears to Protect Coagulation to Leave a Thin Platelet- and Fibrin-Rich Patch Covering the Site of Injury

    A. Yakusheva1,2,3, A. Megalinsky2,4, C. Bourdon1, N. Receveur1, A. Eckly1, A. Shibeko2,3,4, B. Hechler1, D. Nechipurenko2,3,4, C. Gachet1, F. Ataullakhanov2,3,4, M. Panteleev2,3,4, P. Mangin1

  • Abstract Number: PB1703

    The Iron Uptake Receptor Transferrin Receptor 1 (TfR1) Is Required for Proper Platelet and Megakaryocyte Function in Mice

    T. Vögtle1, A. Deuschel1, L.I. Schober1, A. Geier2, H.M. Hermanns2, A. Braun1, B. Nieswandt1

  • Abstract Number: PB0798

    The ISTH DIC Score Predicts Outcome in Non-Septic Patients Admitted to a Cardiovascular Intensive Care Unit

    J. Grafeneder1, K.A. Krychtiuk2, N. Buchtele3, G. Gelbenegger1, M. Lenz2, J. Wojta4, C. Schörgenhofer1, G. Heinz2, K. Huber5, C. Hengstenberg2, B. Jilma1, W. Speidl2

  • Abstract Number: PB0048

    The Level of SPECAM-1 and von Willebrand Factor during the Supraventricular Arrhytmia Episodes in Patients with Arterial Hypertension

    E. Shorikov1, D. Shorikova1, P. Shorikov2

  • Abstract Number: PB0767

    The Mechanism of Antifibrinolytic Action of Anionic Polyamidoamine Dendrimers

    R. Aisina1, L. Mukhametova1,2, E. Ivanova1

  • Abstract Number: PB1518

    The Method of Purification of von Willebrand Factor

    N. Shurko1, Т. Danysh1, V. Novak2

  • Abstract Number: PB0263

    The Misfolded Protein Glycated Albumin Activates the Contact System Leading to Plasma Kallikrein Activity But Not Intrinsic Coagulation

    L. Hardy1, S.L. Heal1, E. Hethershaw1, R. Foster2, C. Longstaff3, T. Renne4, H. Philippou1

  • Abstract Number: PB1125

    The Need for Red Cell Support during Surgery in a Tertiary Care Hospital Is Associated to Pretransfusion Levels of FXIII and the Platelet Count

    S. Listyo1, E. Forrest (†)2, L. Graf1, W. Korte1

  • Abstract Number: PB0598

    The Novel Prothrombin Time (MRX PT DOAC) Assay ‐ Can Be Used to Detect Interfering DOACs in Thrombophilia Investigation

    L. Onelöv1, M. Abelius1, T. Lindahl2

  • Abstract Number: PB1123

    The Obstetric Experience of Carriers of Haemophilia

    O. Turan, D. Pollard, R. Abdul-Kadir

  • Abstract Number: PB0111

    The Optimal Treatment of Atrial Fibrillation in Patients with Cancer

    I. Tzoran, Y. Morgenstern, A. Elias, R. Hoffman, B. Brenner

  • Abstract Number: PB1027

    The Parameters of Modified Clot Waveform Analysis Using the Plasmas of Hemophilia A Patients Treated with Emicizumab

    N. Yamasaki1, K. Kajihara2, H. Nakagawa2, M. Yokozaki3, T. Fujii1

  • Abstract Number: PB0547

    The PFA Results Are Affected by Low Number of Platelets, Low Hematocrit and High Proportion of Immature Platelets

    P. Kessler1, M. Smejkalova1, P. Bradacova2, J. Prokopova1, J. Vagnerova1, J. Ullrychova2, H. Poul1, M. Harudova1, A. Vaskova2, T. Kohoutek2

  • Abstract Number: PB1706

    The Platelet Indices in Patients with Obesity in Najran Area, Saudi Arabia

    O.M. Alshehri1, M.A. Seoudi2, K.A. Sahli3, M.M. Elkhawanky4

  • Abstract Number: PB0438

    The Presence of Anti-Phosphatidylserine/Prothrombin Antibodies Enhance Differences in the Thrombin Generation Phenotype among Subjects with Lupus Anticoagulant Not Meeting Antiphospholipid Syndrome Criteria

    D. Velasco-Rodríguez, R. Vidal Laso, A. García-Raso, I. Mahíllo Fernández, K. Guzmán-López, S. Martín Herrero, E. Jiménez Barral, M.D.C. Vegas-Sánchez, M.J. Martínez Becerra, J.M. Alonso-Domínguez, C. Blas López, R. de la Plaza, L.F. López Romero, D. Mínguez, A. García López, M.S. Sánchez Fernández, P. Llamas-Sillero

  • Abstract Number: PB2243

    The Presence of Paraproteinaemia in Patients with Antiphospholipid Syndrome – A Single Centre Case Series

    A. Doyle, K.A. Breen, B.J. Hunt

  • Abstract Number: PB1303

    The Prevalence of Lupus Anticoagulant in Children and Adolescences Referred to the Reference Coagulation Laboratory of Iranian Blood Transfusion Organization

    M. Mashkooli1, M. Ahmadinejad2, S. Jafari1, T. Pakravan1

  • Abstract Number: PB0117

    The Prevalence of Peripheral Artery Disease in Hospitalized Patients with Heart Failure

    C. Fantoni1, N. Mumoli2, W. Ageno3, M. Silingardi4, L. Bertù3, C. De Dionigi3, M. Giorgi-Pierfranceschi5, V. Gessi3, N. Laganà6, B. Petroboni5, F. Dentali3

  • Abstract Number: PB1351

    The Prevalence, Risk Factors, and Bleeding Tendency of Thrombocytopenia in Patients with Hepatitis C Virus and Hepatitis B Virus Infection

    C.-E. Huang1,2, M.-C. Chen1,3, C.-C. Chen1,4, Y.-Y. Wu1, S.-H. Huang1,3, C.-C. Hsu1, C.-P. Li1

  • Abstract Number: PB2294

    The Prognostic Role of Neutrophil to Lymphocyte Ratio (NLR) in Venous Thromboembolism and Related Mortality

    M.F. Adda'i1,2, A.B. Setyani3, J.H. Haposan2, A.K.T. Haruni4

  • Abstract Number: PB0474

    The Prognostic Role of Red Cell Distribution Width in Venous Thromboembolism and Related Mortality

    M.F. Adda'i1,2, A.B. Setyani3, J.H. Haposan2, A.K.T. Haruni4, A.M. Soesanto5

  • Abstract Number: OC 14.3

    The Proline-Rich Tyrosine Kinase Pyk2 Contributes to Venous Thrombosis

    S. Momi1, J. Canino2, E. Falcinelli1, G. Guglielmini1, L. Galgano2, M. Vismara3, G. Guidetti3, P. Gresele1, M. Torti3, I. Canobbio3

  • Abstract Number: PB2033

    The Protective Effects of PAR1-agonists – Thrombin, Activated Protein C and Peptide 9 in the Model of the Neuroinflammation in vitro

    I. Babkina1, L. Gorbacheva1,2

  • Abstract Number: PB2232

    The Prothrombin Belgrade Mutation Causing Antithrombin Resistance Does Not Affect Fibrin Clot Formation

    S. Dunjic1, M. Cumbo1, I. Pruner2, M. Gvozdenov1, A. Taxiarchis2, B. Tomic1, J. Antovic2,3, V. Djordjevic1

  • Abstract Number: PB1903

    The Prothrombin/MHC II Complexes on Cell-Surface of Monocytes Is the Antigenic Targets in Antiphospoholipid Syndrome

    Y. Fujieda1, N. Ohnishi1, T. Sato1, M. Kono1, M. Kato1, K. Oku1, O. Amengual1, H. Arase2, T. Atsumi1

  • Abstract Number: PB/CO03

    The prothrombotic imbalance between VWF and ADAMTS13 in COVID-19

    I. Mancini1, L. Baronciani2, A. Artoni2, P. Colpani2, M. Biganzoli2, G. Cozzi2, C. Novembrino2, M. Boscolo2, V. De Zan1, S. Aliberti1,3, M. Panigada4, G. Grasselli1,4, F. Blasi1,3, F. Peyvandi1,2

  • Abstract Number: PB2472

    The Psychosocial Impact of Venous Thromboembolism: An Exploratory Systematic Review and Narrative Synthesis

    G. Saul1, E. Gee1, V. Speed1, C. Jordan2

  • Abstract Number: PB1983

    The R398w Gata-2 Variant Negatively Regulates E-Nos Activity: Possible Role in GATA2 Deficiency-associated Thrombosis

    G. Purgatorio1, V. Di Battista2, E. Piselli1, G. Guglielmini1, F. Pellanera2, C. Matteucci2, E. Falcinelli1, L. Bury1, C. Mecucci2, P. Gresele2

  • Abstract Number: PB1741

    The Recombinant Disintegrins Jarastatin and Jararacin and their Inhibitory Activity on Platelet and Endothelial Adhesion

    R. Zingali1, B. Succar1, V. David1, R. Saldanha-Gama2, F. Ceneviva Lacerda de Almeida1, L. Wermelinger Serrão3, C. Barja-Fidallgo2, E. Kurtenbach4

  • Abstract Number: PB1948

    The Red Laser- Mediated Photobiomodulation Therapy, Accompanied by Aspirin Administration, Improve Endothelial Dysfunction after Balloon Angioplasty in the Rabbit Model of Carotid Artery Injury

    H. Mehrad1, A. Foletti2

  • Abstract Number: PB1245

    The Relationship between Platelet Phenotype and Function with Clinical Outcomes in 57 Paediatric Veno-Arterial ECMO Patients

    S. Van Den Helm1, H.P. Yaw1,2, N. Letunica1, R. Barton1,2,3, F. Newall1,2,3, S. Horton2,4, G. MacLaren1,5,6, R. Chiletti5,7, A. Johansen5,7, D. Best5,7, J. McKittrick5, W. Butt2,5,7, Y. d'Udekem1,2,8, M. Linden9, P. Monagle1,2,3, V. Ignjatovic1,2

  • Abstract Number: PB0848

    The Relationship between Societal Costs Associated with Haemophilia and Disease Severity: A Regression Analysis Using CHESS II Data

    T. Burke1, A. Shaikh1, J. O'Hara1,2, N. Misciattelli3, S. Kar3, M. Blanco3, A. Nathwani3,4

  • Abstract Number: OC 07.5

    The Relative Impact of Treatment Approaches on the Outcome of Catastrophic Antiphospholipid Syndrome (CAPS): Analysis of an Updated Database

    P.A. Haddad, D. Hammoud, K. Gallagher

  • Abstract Number: PB2345

    The Review of the Data from the National Registry of Thrombophilic States in the Slovak Republic

    L. Stanciakova, T. Simurda, M. Dobrotova, P. Holly, I. Plamenova, J. Ivankova, K. Kulichova, P. Kubisz, J. Stasko

  • Abstract Number: PB1782

    The Role of Antithrombin in Complement Activation: Pilot Data from Patients with Inherited Antithrombin Deficiency

    K. Mayger1,2,3, J. Young2, R. Greenlaw4, R.A. Smith4, S. Sacks4, B.J. Hunt2

  • Abstract Number: PB2526

    The Role of Antithrombotic Therapy in the Prevention of Adverse Pregnancy Outcomes

    A. Makatsariya, K. Sultangadzhieva, M. Arslanbekova, J. Khizroeva, V. Bitsadze, E. Egorova, N. Babaeva, T. Mashkova

  • Abstract Number: PB0988

    The Role of Clinical Psychologist in Mothers of Children with Hemophilia

    A. Nakao, J. Yamanouchi, T. Hato, K. Takenaka

  • Abstract Number: PB1678

    The Role of Coagulation-generated Components on GPVI-mediated Platelet Activation

    I. De Simone1,2, C. Jones2, J. Gibbins2, H. ten Cate1, J. Heemskerk1, P.E.J. van der Meijden1

  • Abstract Number: PB0039

    The Role of ERp44 in the Atherosclerosis

    Q. Lu

  • Abstract Number: PB0805

    The Role of Genetic and Environmental Factors in Development of Inhibitor in Hemophilia A

    N.B. Mirbehbahani1, A. Rashidbaghan2

  • Abstract Number: PB2061

    The Role of Hemodialysis in Patients with Re-Elevation of Dabigatran Levels After Idarucizumab Treatment: A Case Series

    A. Boban1,2, M. Milos3, C.H. Desiree3, T. Tomic Mahecic4, M. Grgic Medic5, Z. Renata3

  • Abstract Number: PB1276

    The Role of Hereditary Elevated Lipoprotein (a) as a Thrombophilic Risk Factor in Two Siblings with Cerebral Vein Thrombosis

    S. Schober1, C. Deppisch1, U. Holzer1, R. Handgretinger1, U. Ernemann2, N. Kaiser1, V. Icheva1, G. Wiegand1

  • Abstract Number: PB0454

    The Role of Phosphatidylserine-Exposing Microparticles and Glycophorin-Exposing Microparticles in Hemostasis System in Children with Hemolytic Anemia

    E. Seregina1,2, E. Lipets1,2, A. Poletaev1, T. Vuimo1,2, F. Ataullakhanov1,2,3, N. Smetanina1,4

  • Abstract Number: PB1683

    The Role of Platelets in the Adhesion of Normal Freshly Isolated Lymphocytes to Fibrin

    A. Solpov1, E. Bogomyakova2, O. Solpova3, Y. Vitkovsky4

  • Abstract Number: PB1225

    The Role of the Nurse in the Therapeutic Education of Hemophiliac Patients in Preparation for Physiotherapy

    M. Djaafri, D. Saidi, R. Messaoudi, H. Touhami

  • Abstract Number: PB0406

    The Role of the Protein C Pathway in Hemostasis: The Importance of Physiological Context

    T.T. Marar1, L. Nettey1, C. Matzko1, I. Poventud-Fuentes1, C.T. Esmon2, T.R. Sinno3, L.F. Brass1, T.J. Stalker1, M. Tomaiuolo1

  • Abstract Number: PB1554

    The Role of the von Willebrand Factor Propeptide (VWFpp) in the Evaluation of Desmopressin Response in a Patient with Acquired von Willebrand Syndrome (AVWS)

    P. Colpani1, L. Baronciani1, G. Cozzi1, S.M. Siboni1, E. Biguzzi1, C. Novembrino1, F. Rossi1, F. Peyvandi1,2

  • Abstract Number: PB0874

    The Role of Ultrasonography versus MRI in the Diagnosis of Joint Problems in Hemophilic Children

    O. El Safi1, M. Besheer1, M. Fathy1, S. Shehata2, M. Abdel Fatah1, M. Gabal2, M. Amin2, A. Osama3

  • Abstract Number: PB1997

    The Role of α1AMP-Activated Protein Kinase (α1AMPK) in Haemostatic Dysfunctions Induced by Sepsis

    J. De Poortere1, M. Angé1, L. Bertrand1, C. Beauloye1,2, S. Horman1, D. Castanares-Zapatero1,3

  • Abstract Number: PB1524

    The Scavenger Receptor Scara5 Mediates Clearance of the von Willebrand Factor Propeptide

    O. Rawley, K. Nesbitt, C. Dwyer, L. Swystun, D. Lillicrap

  • Abstract Number: PB2341

    The Season Role in the Occurrence of Thromboembolic Disease

    W. Skouri1, F. Said2, I. Naceur2, H. Baccouche3, M. Lamloum1, I. Ben Ghorbel1, M. Khanfir2, M.H. Houman2, N. Ben Romdhane3

  • Abstract Number: PB0513

    The Sensitivity of Two New APTT Reagents to Factors VIII, IX and XI

    A. Bowyer, S. Kitchen, R. Maclean

  • Abstract Number: PB0602

    The Severity of Hemophilia A Patients Varies among Different Types of Factor VIII Gene Mutation

    Y. Li1, W. Jin1, Q. Li2, L. Li1

  • Abstract Number: PB2184

    The Sex-Related Risk of Venous Thromboembolism Attributed to Recognized Prothrombotic Genotypes

    C.A.L. Arnesen1, L.H. Evensen1, K. Hveem2,3, M.E. Gabrielsen2,3, B.M. Brumpton2,4, J.-B. Hansen1,5, S.K. Brækkan1,5

  • Abstract Number: PB2293

    The Significance of Haemostatic System’s Changes in the Assessing of Unfavorable Prognosis in Patients with Burn Injury

    E. Klychnikova, V. Borisov, E. Tazina, A. Bogdanova, M. Kaplunova

  • Abstract Number: PB1354

    The Significance of Platelet Factor 4 (Pf4 Antibody) in Diabetic and Non-Diabetic Population during Heparin Therapy In Pakistan

    R.A. Abbasi1, I.D. Ujjan1, A. Naz2, K. Amir1, N. Hafeez1

  • Abstract Number: PB0618

    The SSC Working Party on Thrombin Generation: Inventory of Thrombin Generation Methods

    M. Ninivaggi1, R. de Laat-Kremers1, K. Devreese2,3, B. de Laat1

  • Abstract Number: PB0049

    The State of Carotids and the von Willebrand Factor Levels in Patients with Arterial Hypertension

    E. Shorikov1, D. Shorikova1, P. Shorikov2, O. Khukhlina1

  • Abstract Number: PB1529

    The Super Glue of Ultra-Large Multimers – Characterisation of Recombinant and Platelet Derived von Willebrand Factor

    T. Kragh1, M. Spannagl1, H.W. Ott2, P. Möhnle1,3, I. Pekrul1,3

  • Abstract Number: PB1975

    The survival of endothelial cells in the conditions of nutrient deficiency

    T. Nikolaienko, L. Garmanchuk, V. Nikulina

  • Abstract Number: PB0852

    The Synergistic Effect of Emicizumab and Factor VIIa on Thrombin Generation Is Dependent on Factor VIIa Activation of Factor IX

    D. Monroe1, M. Ezban2, M. Hoffman3,4

  • Abstract Number: PB1289

    The Throm-PED Registry: The Cornerstone of the International Pediatric Thrombosis Network

    C.H. van Ommen1, M. Albisetti2, M. Bhatt3, M. Bonduel4, M. Bordbar5, B. Branchford6, E. Chalmers7, A. Chan3, S. Holzhauer8, J. Jaffray9, C. Male10, P. Monagle11, U. Nowak-Göttl12, L. Raffini13, S. Revel-Vilk14, N. Sirachainan15, IPTN Consortium

  • Abstract Number: PB1987

    The Tissue Factor Expression of Monocyte Subsets and the Activation of Coagulation during Human Endotoxaemia

    K. Musgrave1,2, J. Scott1, W. Sendama1,3, H.M.H. Spronk4, R. van Oerle4, H. ten Cate4, P. Kesteven2, M.-H. Ruchaud-Sparagano1, A. Rostron1,5, A.J. Simpson1,3

  • Abstract Number: PB1986

    The Tissue Factor Surface Expression of Monocyte Subsets during Sepsis

    K.M. Musgrave1,2, J. Scott1, W. Sendama1,3, P. Kesteven2, M.-H. Ruchaud-Sparagano1, A. Rostron1,4, A.J. Simpson1,3

  • Abstract Number: PB2272

    The Use of ADJUST (age-adjusted) D-Dimer Cut-off in the Assessment of Individuals Over 50 Years Old with Suspected Deep Vein Thromboses Can Decrease the Need for Compression Ultrasonography: Initial Results of a Prospective Primary Care Study

    A. Hughes, B. Piper, K. Jennings, K. North, B. Varghese, D. Kawira, M. Good, K. Good

  • Abstract Number: PB0506

    The use of an Automated Thrombin Generation Assay for the Measurement of Emicizumab and Recombinant Factor VIII in Spiked Plasma

    A. Bowyer, S. Kitchen, R. Wardle, R. Maclean

  • Abstract Number: PB2410

    The Use of Fondaparinux for Recurrent Thrombotic Events

    Z. Sayar, S. Burke, H. Cohen

  • Abstract Number: PB0108

    The Use of in Vitro Clot Lysis Assay for Predicting Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients

    R. Orbán-Kálmándi1, T. Árokszállási2, I. Fekete2, K. Fekete2, M. Héja2, J. Tóth3, F. Sarkady1, L. Csiba2, Z. Bagoly1,4

  • Abstract Number: PB0485

    The Use of Platelet Transfusions during Extracorporeal Membrane Oxygenation in a Large Tertiary Centre

    A. Doyle1, B. Sanderson2, F. Vasques2, D. Wyncoll2, N.A. Barrett2, B.J. Hunt1, L. Camporota2, A. Retter2

  • Abstract Number: PB2482

    The Use of Thrombolytic Therapy in a Multidisciplinary Pulmonary Embolism Response Team

    A. Kramer1,2, C.S. Mortensen1,2, J.G. Schultz1,2, N. Giordano1, H. Zheng3, A. Andersen2, J.E. Nielsen-Kudsk2, C. Kabrhel1

  • Abstract Number: PB1422

    The Utility of a Platelet Count-Based Electronic Medical Record Alert to Facilitate Diagnosis of Heparin-Induced Thrombocytopenia

    J. May1, L. Taylor2, P.W. Varden2, E. Wallace3, M. Marques4

  • Abstract Number: PB1543

    The Utility of ISTH-BAT in Iranian Patients with von Willebrand Disease

    O. Seidi Zadeh, M. Ahmadinejad

  • Abstract Number: PB0772

    The VWF/ADAMTS13 Unbalance, but Not Global Coagulation or Fibrinolytic Status, Is Associated with Outcome and Bleeding in Patients with Acute Liver Failure

    E. Driever1, R.T. Stravitz2, J. Zhang3, J. Adelmeijer1, V. Durkalski3, W.M. Lee4, T. Lisman1

  • Abstract Number: PB1098

    The World Federation of Hemophilia Gene Therapy Registry

    B. Konkle1,2, D. Coffin1, M. Naccache1, C. Cary3, L.A. George4, A. Iorio5, B. O'Mahony6, S.W. Pipe7, M.W. Skinner8, C. Watson9, F. Peyvandi10,11, J.N. Mahlangu12,13, G.F. Pierce1

  • Abstract Number: PB1419

    Therapeutic Plasma Exchange in the Pre-Operative Management of Acute HIT

    C. Cavalié, N. Gendron, S. Provenchère, R. Sonneville, E. Kantor, D. Faille, N. Ajzenberg

  • Abstract Number: PB0710

    Thermostable Inhibitor of Contact Activation (TICA) Fully Blocks Contact Activation when Added to Blood Withdrawal Tubes

    T. van de Berg1,2, D. Suylen1, S. Thomassen1, R. van Oerle1, H. Spronk1, R. Apitz3, C. Hemker1, T. Hackeng1

  • Abstract Number: PB0997

    Third Time´s the Charm? Tachyphylaxis of Desmopressin Response in Non-Severe Hemophilia A Patients and Comparison to Earlier Response: The DAVID Study

    L.G.R. Romano1, L.M. Schütte1, R.M. van Hest2, K. Meijer3, B.A.P. Laros-van Gorkom4, L. Nieuwenhuizen5, J. Eikenboom6, F.C.J.I. Moenen7, N. Uitslager8, M. Coppens9, M.H. Cnossen10, K. Fijnvandraat11,12, M.H.E. Driessens13, S. Polinder14, F.W.G. Leebeek1, R.A.A. Mahtôt2, M.J.H.A. Kruip1

  • Abstract Number: PB0389

    Thr90Ser Mutation in Antithrombin Causes Recurrent Thrombosis in a Heterozygous Carrier

    Y. Lu1,2, B.O. Villoutreix3, Q. Ding1, X. Wang1, A.R. Rezaie2,4

  • Abstract Number: PB2170

    ThroLy and Khorana Scores Comparation in a Group of Lymphoma Patients

    P. Llamas1, A. Garcia Raso2, A. Lopez2, J.M. Alonso2, D. Velasco2, D. Morillo2, C. Dbouk2, R. Vidal2, R. Cordoba2

  • Abstract Number: PB0567

    Thrombin Generation Analysis in Patients with Venous Thromboembolism and Atrial Fibrillation on Anticoagulant Tehrapy: Comparison between Direct Oral Anticoagulants and Antivitamin K Antagonists

    C. Dellanoce, O. Paoletti, V. Cancelli, E. Cancellieri, R. Morandini, B. Kaur, M. Tala, S. Zambelli, S. Testa

  • Abstract Number: PB1030

    Thrombin Generation Assay to Tailored Treatment in Hemophilia a Patients

    M.D.L. Herrera1,2, S. Pons1,2, E. Sueldo3, M. Arias3, A. Baques4, P. Do Nascimento4, A. Scazziota1,2

  • Abstract Number: PB0138

    Thrombin Generation Following Vipera berus Envenomation: A Canine Model

    H.J. Harjen1, M. Hellum2,3, M. Oscarson1, R. Rørtveit4, K.P. Anfinsen1, E.R. Moldal1, C.E. Henriksson2,3

  • Abstract Number: PB0106

    Thrombin Generation in Patients with Non-traumatic Intracerebral Hemorrhage

    L. Lóczi1, T. Árokszállási2, I. Fekete2, K. Fekete2, M. Héja2, F. Sarkady1, R. Orbán-Kálmándi1, J. Tóth3, L. Csiba2, Z. Bagoly1,4

  • Abstract Number: PB/CO17

    Thrombin Generation in Severe COVID-19 Patients Hospitalized in the ICU

    M.G. Zermatten1, F.J. Gomez1, O. Pantet2, M. Papadimitriou-Olivgeris3,4, O. Hugli5, P.-A. Bart6, A. Aliotta1, D. Bertaggia Calderara1, M. Méan6, L. Mazzolai7, L. Alberio1, The COVID-19 Interdisciplinary Collaboration

  • Abstract Number: PB0903

    Thrombin Generation is a Better Predictor for Factor VIII Replacement Therapy Effect Than Factor VIII Activity Levels

    L.L.F.G. Valke1,2, L.H. Bukkems3, N.M.A. Blijlevens1, R.A.A. Mathôt3, W.L. Van Heerde2,4, S.E.M. Schols1,2

  • Abstract Number: PB1247

    Thrombin Generation Measurement Using ST-Genesia System in a Cohort of Healthy Children Including Neonates: Normal Values and Variability

    P. Nguyen1,2, L. Kanagaratnam3, C. Deleage1, C. Amory4, N. Bednarek5, C. Ballan1, N. Hezard6

  • Abstract Number: PB1146

    Thrombin Generation Potential of Modified FIX: Dalcinonacog Alfa

    S. Williams, E. Gray

  • Abstract Number: PB0054

    Thrombin-Induced Platelet Fibrin Clot Strength Identified by Thromboelastography: A Potential Marker of Increased Thrombotic Risk in Older Adults with Coronary Artery Disease

    R. Chaudhary1, S. Pagali1, K. Bliden2, U. Tantry2, P. Gurbel2

  • Abstract Number: OC 14.5

    Thrombin-PAR1/2 Signaling Axis Modulates TLR3-Mediated Procoagulant, Proinflammatory, and Proadhesive Responses in Vascular Endothelial Cells

    S. Subramaniam1,2,3

  • Abstract Number: PB0311

    Thrombocytopenia in adult ICU patients with sepsis

    L. Russell, N. Haase, A. Perner

  • Abstract Number: PB0482

    Thromboelastometry Identifies Coagulopathy Associated with Liver Failure and DIC Caused by Yellow Fever, Guiding Specific Hemostatic Therapy: A Case Report

    T. Crochemore, F. Savioli

  • Abstract Number: PB0086

    Thromboembolism in Thalassemia Patients: Is Aspirin Protective against Brain Ischemia over Three Years Follow Up in Beta Thalassemia Patients?

    M. Karimi1, S. Haghpanah1, P. Eshghi2

  • Abstract Number: PB0275

    Thrombohemorragic Events and Management of Haemostasis in Adult Patients under Berlin Heart Excor Devices

    M. Argüello1, E. Zatarain2, G. Pérez-Rus1, I. Sousa2, M.J. Valero2, J. Velásquez2, M. Martínez-Sellés2, J.L. Diez-Martin1, C. Ortiz2, C. Pascual1

  • Abstract Number: PB2030

    Thrombomodulin Makes the Difference – Novel Role of Protease-Activated Receptor 4 as Low-Dose Thrombin Receptor

    D.M. Heuberger, D. Ardizzone, R.A. Schuepbach

  • Abstract Number: PB0006

    Thrombophilia and Myocardial Infarction with Non-Obstructive Coronary Arteries

    A. Golub1, I. Bokarev2, L. Popova3, T. Khlevchuk1, M. Kanevskaia1, T. Kondrateva1, M. Aksenova1, A. Gerasimov3, L. Patrushev4, T. Kovalenko4, Y. Belenkov1

  • Abstract Number: PB2241

    Thrombophilia and Thrombotic Complications in Armenia

    H. Khachatryan1, L. Sahakyan2, N. Sargsyan1,3, L. Petrosyan1, L. Hambardzumyan2,4, I. Melnichenko3,4, S. Petrosyan5, G. Tamamyan3,4, S. Danielyan2

  • Abstract Number: PB2180

    Thrombophilia Gene Screening in Pediatrics Solid Tumors with Thrombosis

    O. El Safy1, M. Fathy1, A. Osama2, M. Zakaria1, S. Fehr1, N. Raafat3

  • Abstract Number: PB2230

    Thrombophilia Testing in Algerian Pediatric Patients

    I. Hocine, Y. Ferhat-Hamida, G. Hariti

  • Abstract Number: PB2228

    Thrombophilia Testing in Patients with Arterial Thrombosis in Routine Clinical Practice

    G.A. Méndez Navarro

  • Abstract Number: PB2245

    Thrombophilic Abnormalities Screening in Elderly Women Patients with Venous Thrombosis

    L. Hurjui1,2, L.I. Șerban1, C. Delianu1, I.A. Hurjui1, R.M. Hârțan1, C.C. Tarniceriu1, I. Hurjui1, I. Gradinaru1

  • Abstract Number: PB2248

    Thrombophilic Mutations in Macedonian Women with Adverse Pregnancy Outcome

    E. Petkovikj1, A. Hristova Dimceva1, R. Grubovic1, S. Useini1, V. Petkovska1, T. Makarovska Bojadzieva1, E. Ristovska2

  • Abstract Number: PB1610

    Thrombopoiesis in Bone Marrow Culture in Norm and in Some Pathological States

    T. Saralidze1, T. Svanidze1, I. Mamatsashvili1, N. Metskhvarishvili2, M. Rizhvadze3, M. Jangidze4, M. Noniashvili1

  • Abstract Number: PB2035

    Thrombopoietin Rescues Megakaryopoiesis, Reduces Hemorrhage via Protecting Bone Marrow Endothelial Function of Chemotherapy-Treated Hematological Malignancies Patients

    X. Zeng, Y. Jiao, Z. Li, Y. Zhang, J. Ye

  • Abstract Number: PB2386

    Thromboprophylaxis Audit in a Public Hospital – The Impact of Protocol Implementation

    P.H. Fernandes do Carmo Las Casas1, J.E. Machado Veloso1, D. Coelho Cavalcante1, M. Fernandes Nogueira1, A.L. Ferreira de Brita1, M. Aredes Lima1, A. Gorle de Miranda Chaves1, F.C. Barbosa Lana2, I. Almeida Pessoa1

  • Abstract Number: PB2525

    Thromboprophylaxis during Pregnancy – 10-year Review of Women Seen in the Haematology Clinic at King’s College Hospital (KCH)

    N. Rajaratnam1, J. Patel1,2, L. Roberts2, J. Czuprynska2, R. Patel2, R. Arya2

  • Abstract Number: PB2356

    Thromboprophylaxis to International Conferences and Number of Thromboses (PINOT) study

    H. Stevens1,2,3, S. Campbell2,4, N. Waters5, J. McFadyen1,2,3, H. Tran1,2

  • Abstract Number: PB2137

    Thromboprophylaxis with Rivaroxaban in Patients with Malignancy and Central Venous Lines (TRIM-line): a Multi-centre Open-label Pilot Randomized Controlled Trial

    R. Ikesaka1, D. Siegal2, D. Witham3, C. Webb4, M. Carrier5

  • Abstract Number: PB1290

    Thrombosis and Anticoagulant Therapy among Pediatric Patients with Active Cancer: Real Life Data

    H. Abdel-Razeq, M. Zeineddin, N. Amayiri, W. Alqasem, I. Sultan, B. Hammo, H. Hashem

  • Abstract Number: PB1935

    Thrombosis and Antiphospholipid Antibodies

    I. Nikoloska, R. Apostolovska, V. Neceva, S. Useini

  • Abstract Number: PB1291

    Thrombosis and Laboratory Monitoring in Children with Acute Lymphoblastic Leukemia

    E. Seregina1,2, L. Zharikova1, N. Trubina1, M. Korsantiya1, M. Gracheva1, T. Vuimo1,2, A. Poletaev1, F. Ataullakhanov1,2,3

  • Abstract Number: PB2106

    Thrombosis in Hematologic Malignancies: A Five Year Single-Center Experience in Mexico

    C. Ledesma de la Cruz1, M.T. García-Lee1, L.O. Guzmán-Chores1, J.E. Castellanos-Galán1, Y. Lugo-García1, J. Juárez-Lara1, A.S. Majluf-Cruz2

  • Abstract Number: LB/CO01.2

    Thrombosis, Bleeding, and the Effect of Anticoagulation on Survival in Critically Ill Patients with COVID-19 in the United States

    H. Al-Samkari1,2, S. Gupta2,3, R. Karp Leaf1,2, W. Wang4, R. Rosovsky1,2, K. Bauer2,5, D. Leaf2,3, STOP-COVID Investigators

  • Abstract Number: PB1622

    Thrombotic Disease Caused by Hypothermia-Induced Activation of the Splenic Platelet Pool in a Mouse Model

    K. Horioka1, H. Tanaka2, S. Isozaki2, H. Druid1

  • Abstract Number: PB1214

    Thrombotic Events in the Patients with Haemorrhagic Disorders of Haemostasis

    L. Stanciakova1, M. Dobrotova1, P. Holly1, M. Brunclikova1, M. Samos2, T. Bolek2, P. Kubisz1, J. Stasko1

  • Abstract Number: PB1912

    Thrombotic Outcomes in Pregnant Women with Antiphospholipid Antibodies in a Tertiary Referral Centre

    A. Rottenstreich1,2, K. Schreiber1, M. Frishman1, K. Breen1, S. Robinson1, M.J. Cuadrado1, M.A. Khamashta1, B.J. Hunt1

  • Abstract Number: PB0705

    Thrombus Formation Study of Upstream Activation and Downstream Adhesion of Platelets in a Highly Integrated Microfluidic System

    S. Xu, J. Piao, S. Shin

  • Abstract Number: PB1397

    Ticagrelor Mechanism of Action on Gram-Positive Bacteria

    L. Musumeci1, N. Jacques1, N. Penoy2, G. Piel2, E. Goffin2, B. Pirotte2, A.M. Amoroso3, B. Joris3, O. Verlaine3, P. Lancellotti1,4, C. Oury1

  • Abstract Number: PB2072

    Time in Therapeutic Range During Therapy with Vitamin K Antagonists Is Lower in Women than in Men and Is Not Explained by Differences in Age

    I. Avarello1, M.L. Zighetti1, V. Toschi1, E.M. Faioni1,2

  • Abstract Number: PB2447

    Time in Therapeutic Range in Venous Thromboembolic Diseases in a North African Geriatric Population

    M. Mrouki, S. Zrida, Y. Cherif, S. Derbel, F. Ben Dahmen, M. Abdallah

  • Abstract Number: PB2205

    Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (The TILE Pilot Study): Rationale and Study Protocol

    J.P. Galanaud1, J. Abdulrehman2, A. Delluc3, S. Schulman4, S. Kahn5

  • Abstract Number: PB0055

    Tissue Factor Cytoplasmic Tail Promotes Inflammatory Myeloid Cell Derived Superoxide Formation and TGF-β1 Driven Cardiac Remodeling in Myocardial Infarction

    V. Garlapati1,2, M. Molitor1,2,3, P. Efentakis1, J. Lagrange1, R. Schüler1,3, J. Wild1,2,3, M. Knorr1,3, S. Karbach1,2,3, K. Vujacic-Mirski3, T. Münzel1,2,3, A. Daiber2,3, M. Brandt1,2,3, S. Kossmann1,3,4, H. Milting5, T. Gori2,3, W. Ruf1,2,6, P. Wenzel1,2,3

  • Abstract Number: PB0417

    Tissue Factor Pathway Inhibitor Is Increased in Plasma of Patients with a mild to Moderate Bleeding Tendency Independent of Known Genetic Variations in the factor V Encoding Gene

    D. Mehic1, A. Tolios2, S. Hofer1, H. Haslacher3, J. Rejtö1, C. Ay1, M. Haimel4, I. Pabinger1, W. Ouwehand5, K. Downes5, J. Gebhart1

  • Abstract Number: PB2329

    Tissue Factor Pathway Inhibitor, Activated Protein C Resistance and Risk of Venous Thrombosis Associated with Menopausal Hormone Therapy

    D. Khialani1, S. Vasan2, M. Cushman3, A. Dahm4, P. Morten Sandset4, J. Rossouw5, A. van Hylckama Vlieg1

  • Abstract Number: PB0231

    To Determine the Effect on Gender and Age of Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT) Levels and International Normalized Ratio (INR)

    A. Sultana

  • Abstract Number: PB0746

    To Evaluate the Effect of Hydroxyurea on Blood Coagulation and Endothelial Activation in Sickle Cell Disease

    M. Borhany, M. Abid, S. Zafar, T. Shamsi

  • Abstract Number: PB1827

    Toll-Like Receptor 2 Ligands Promote and Enhance Platelet Activation

    I. Parra-Izquierdo, A.R. Melrose, S. Hitesh, J. Pang, O.J.T. McCarty, J.E. Aslan

  • Abstract Number: PB0672

    Top 50 Cited Papers in Developmental Hemostasis: A Scoping Review

    P.T. Tieu1,2, S. Afraz2, H.M. Ho3, N. Thai4, A.K.C. Chan2,5, D. Matino2

  • Abstract Number: PB0752

    Total and C-terminally Truncated Alpha2-plasmin Inhibitor Levels in Venous Thrombosis

    É. Katona, B. Baráth, T. Miklós, D. Pituk, V. Fedoriska, L. Muszbek, Z. Bereczky

  • Abstract Number: PB0884

    Total Elbow Replacement: Financial Burden Impact

    J. Restrepo-Avenia, J.H. Ramirez-Varela, J.E. Duque-Gil

  • Abstract Number: PB0931

    Total Hip Arthroplasty In Avascular Necrosis of the Femoral Head in a Patient with Hemophilia A

    J. Cabral, D. Brito, M. Calheiros, C. Calaza, A. Marques

  • Abstract Number: PB1078

    Total Knee Arthroplasty in Patients with Hemophilia A and B: Impact on Quality of Life

    A. Nunes Loureiro Prezotti, J. Souza Mario Duarte, S. Soraya Marcondes, M.D.P.S. Vendramini Orletti, D. Maria do Carmo Rocha, A. Rocha Neto, B. Calatrone Altoe, L. Souza Arnoni, B. Prucoli, G. Louredo, C.R. Silva Pacheco, L. Lacerda Montezi

  • Abstract Number: PB1361

    TOutcomes of Patients with Worsening Acquired Thrombotic Thrombocytopenic Purpura (TTP) Despite Daily Therapeutic Plasma Exchange (TPE) in the Phase 3 HERCULES Trial

    M. Scully1, J. de la Rubia2,3, F. Peyvandi4,5, S. Cataland6, P. Coppo7, J.A. Kremer Hovinga8, P. Knoebl9, K. Pavenski10, F. Callewaert11, J. Minkue Mi Edou12, R. de Passos Sousa13

  • Abstract Number: PB1722

    Towards Complete Assignment of the Full Platelet Proteome and Transcriptome

    J. Huang1,2, I. Provenzale1, L. Grassi3, F.M. Solari2, A. Sickmann2, M. Frontini3, J.W.M. Heemskerk1, F. Swieiringa1

  • Abstract Number: PB2073

    Towards Individualizing Apixaban Therapy in Elderly Patients Through Thrombin Generation

    A. Scazziota1,2, S. Pons1,2, M.D.L. Herrera1,2, S. Aguirre1,3, V. Monserrat1,3, M. Nuñez4, A. Brodsky5, R. Perez de la Hoz6

  • Abstract Number: PB1702

    Towards the Correlation of Age with Size in Human Platelets under Steady State

    M. Wolff, S. Handtke, A. Greinacher, T. Thiele

  • Abstract Number: PB0724

    Transcriptome Profiling of Coagulation Factor XIII Genes: Implications for Pleiotropic Pathways and Inter-Subunit Regulation

    M.A. Jamil1, S. Singh1, A.S. Wolberg2, O. El-Maarri1, J. Oldenburg1, A. Biswas1

  • Abstract Number: PB0740

    Transition Patterns in the Fibrinolytic Response are Superior to Admission ROTEM Values in Stratifying Risk for Late Clinical Outcomes after Major Trauma

    A. Rossetto1,2, P. Vulliamy1,2, K. Brohi1,2, R. Davenport1,2

  • Abstract Number: PB0193

    Transplacental Delivery of Fc-fused Factor VIII (rFVIIIFc) in FVIII-Deficient Mice

    S. Delignat1, A. Azam1, A. Mimoun1, M. Georgescu2, D. Lillicrap2, S. Lacroix-Desmazes1

  • Abstract Number: PB0177

    Transplacental Delivery of Maternal Factor VIII for Induction of Immune Tolerance to Therapeutic Factor VIII

    A. Mimoun1,2, M. Bou Jaoudeh1,2, I. Peyron3,4, V. Daventure1,2, S. Delignat1,2, O. Christophe3,4, P. Lenting3,4, C. Denis3,4, L.-D. Sébastien1,2

  • Abstract Number: PB2037

    Transplantation of Fetal Liver Cells into Newborn Hemophilic Mice for Hemophilia A Cell Therapy

    S. Merlin1, S. Buzzi1, S. Akula1, E. Borroni1, V. Kalandadze1, T. Garcia-Leal2, L.J. Serrano3, A. Liras3, M.J. Sanchez2, A. Follenzi1

  • Abstract Number: PB0033

    Trash Feet: Is Anticoagulation Therapy Useful?

    V. Chadachan, N. Pandit

  • Abstract Number: PB1918

    Treating Antiphospholipid Syndrome Patients with Vitamin K Inhibitors in Real Life; Long Term Outcomes from a Single Centre Retrospective Study of 101 Patients

    I. Venkatadasari, G. McIlroy, M. Ahmed, M. Any, M. Kaparou, C. Kartsios

  • Abstract Number: PB0331

    Treatment and Joint Health in Nordic Moderate Haemophilia Patients – the Mohem Study

    R.J. Måseide1,2,3, E. Berntorp4, J. Astermark5, A. Olsson6, M. Bruzelius7,8, T. Frisk9, V. Nummi10, R. Lassila10, G.E. Tjønnfjord1,3, P.A. Holme1,2,3

  • Abstract Number: PB1892

    Treatment of Acquired Thrombotic Thrombocytopenic Purpura in Rituximab Era: A Single Center Experience from India

    N. Gupta1, S. Langer2, A. Saraf2, J. Kotwal2, A. Sharma1

  • Abstract Number: OC 12.5

    Treatment of Heavy Menstrual Bleeding in a Multidisciplinary Young Women’s Bleeding Clinic for Adolescents: An Institutional 2-year Experience

    M.C. Brown1,2, R.F. Sidonio Jr.1,2

  • Abstract Number: PB1050

    Treatment of Hemophilia A with rVIII-SingleChain in Italy: Physician and Patient Survey

    A. Borchiellini1, G. Castaman2, G. Feola3, A. Ferretti4, P. Giordano5, M. Luciani6, G. Malcangi7, M. Margaglione8, A.C. Molinari9, B. Pollio10, A. Rocino11, E. Santagostino12, C. Santoro4, R. Santoro13, M. Schiavulli14, E. Zanon15

  • Abstract Number: PB0888

    Treatment of Hemophilic Arthropathy with Hyaluron

    A. Makhmudova, I. Berger, L. Ashurova, N. Akhrarova, O. Madasheva

  • Abstract Number: PB1339

    Treatment of Immune Thrombocytopenia with Eltombopag in Children: Single Center Experience

    A. Ayhan

  • Abstract Number: PB1120

    Treatment Options in Severe Hemophilia A Patients from Romania: What Role did the Intron 22 Inversion and Age Play?

    M.-A. Gaman1,2, M. Brinza3, V. Uscatescu3, A. Diaconu3, A. Grigore4, M. Dragomir3, D. Coriu1

  • Abstract Number: PB1020

    Treatment Patterns and Bleeding Outcomes in Persons with Severe Hemophilia A and B in a Real-World Setting

    L. Perschy1, J. Rejtö1, I. Pabinger1, C. Ay1, A. Kaider2

  • Abstract Number: PB1556

    Treatment with Emicizumab Leads to Clinical Improvement in a Type 3 von Willebrand Disease Patient with Inhibitor Suffering from a Left Ankle Arthropathy

    M. Sigaud1, M. Fouassier1, C. Ternisien1, M. Pennetier2, M. Trossaert1, N. Drillaud1

  • Abstract Number: PB0955

    Treatment-Based Risk Assessment of Developing Pain, Anxiety, and Depression as Compared to Matched Controls in People with Haemophilia. A Nordic Registry Study Over a Period of 11 Years

    K. Steen Carlsson1,2, B. Winding3, J. Astermark4, F. Baghaei5, E. Brodin5, E. Funding6, M. Holmström7, K. Österholm8, S. Bergenstråle3, E. Andersson1, S. Lethagen3,9

  • Abstract Number: PB1613

    TREM-like Transcript-1 Is a Positive Regulator of Platelet Production and Thrombosis

    C.W. Smith1, V.A. Washington2, Y.A. Senis3, A. Mazharian3

  • Abstract Number: PB2497

    Trends in Combined Oral Contraceptive Use in the Netherlands: 2002-2016

    D. Khialani, F. Rosendaal, A. van Hylckama Vlieg

  • Abstract Number: PB2090

    Trends in Direct Oral Anticoagulant Use in Renal Failure

    S. Kaatz1, B. Haymart2, X. Kong2, M. Ali3, E. Kline-Rogers2, J. Kozlowski4, G. Krol1, V. Shah1, G.D. Barnes2, J.B. Froehlich2

  • Abstract Number: PB1974

    Trimethylamine N-oxide (TMAO) Disrupts Haemostasis Balance in Human Vascular Endothelial Cells

    S. Subramaniam1,2, S. Boukhlouf3, C. Fletcher1

  • Abstract Number: PB1955

    Tripeptides Affected Hemostas in Various Pathologies

    M. Golubeva, B. Umarova

  • Abstract Number: PB1927

    Triple Positive Antiphospholipid Antibodies: A 10-year Retrospective Review of 37 Patients with Triple Positive Antiphospholipid Antibodies and their Thrombotic Outcomes and Mortality in a Single Centre in Singapore

    B.E. Fan1,2, C.L.L. Sum3

  • Abstract Number: PB1976

    TRPV4 Channel Activation Induces the Transition of Venous and Arterial Endothelial Cells Toward a Pro-Inflammatory Phenotype

    K. Beddek1, F. Raffin2, D. Borgel1, F. Saller1, D. Riccobono3, F.-X. Boittin3, R. Bobe1

  • Abstract Number: PB1799

    Tumor Platelet Transcriptome Changes in Hyperthrombotic Mice

    C. Santos1, J. Braun1, S. Schubert1, F. Marini1,2, B. Schrörs3, L. Bresadola3, P. Do Dinh3, R. Wolfram1,4

  • Abstract Number: PB0693

    Two Cases in which Measuring Dabigatran Plasma Levels Is Indicated and Recommended

    D.I. Iosub1, F. Piovella2

  • Abstract Number: PB2387

    Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER Study): Final Analysis of 242 Patients

    E. Merriman1, S. Chunilal2, S. McRae3, T. Brighton4, P. Ockelford5, H. Tran6, J. Curnow7, V. Chen8, B. Chong9, M. Smith10, G. Royle11, H. Crowther12, A. Slocombe13, A. Cummins14, H. Tran15,16

  • Abstract Number: PB0837

    Two-year Update on the WFH World Bleeding Disorders Registry

    M. Naccache1, D. Coffin1, W. Youttananukorn1, E. Tootoonchian1, V. Byams2, S. Diop3, C. Hermans4, D. Noone5, J. O'Hara6, G.F. Pierce1, A. Iorio7, B. Konkle8, E. Ayoub1

  • Abstract Number: PB1534

    Type 2B Mutations Differentially Alter Conformational Dynamics of VWF A1 Domain

    E.R. Legan, N.A. Arce, Y. Wang, P. Lollar, R. Li

  • Abstract Number: PB1585

    Type 2N von Willebrand Disease (VWD2N): Is it Always a Recessive Trait?

    A.I. Woods1, L. Rossetti2, J. Paiva3, M.L. Romero3, A.N. Blanco3, M.M. Casinelli3, C. De Brasi2,4, A. Sanchez-Luceros1,3

  • Abstract Number: PB1686

    Tyrosine Kinase Inhibitor Sunitinib Delays Platelet-induced Coagulation: Additive Effects of Aspirin

    B.M.E. Tullemans1, D.I. Fernández1, A. Veninga1, M.J.B. Aarts2, P.E.J. van der Meijden1, J.W.M. Heemskerk1, M.J.E. Kuijpers1

  • Abstract Number: PB1458

    Tyrosine Kinase Inhibitors (TKIs) Targeting Syk and BTK Signaling Differentially Affect PI3K Organization and Inhibit Platelet Function

    T. Zheng, E. Lofurno, A. Melrose, J. Pang, J. Shatzel, O. McCarty, J. Aslan

Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.